Clinical Trial Update: Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

View source ↗

Summary

A completed clinical trial investigated the use of isosulfan blue for visceral lymphatic mapping in patients with cancers of the pancreas, colon, stomach, small…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer
• Gallbladder Cancer
• Gastric Cancer
• Pancreatic Cancer
• Small Intestine Cancer

Drugs mentioned

• Isosulfan blue (Isosulfan blue)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Colorectal Cancer, Gallbladder Cancer | Status: COMPLETED